NovoCure Limited Free Cash Flow Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD -0.66

NovoCure Limited Free Cash Flow Per Share is USD -0.66 for the Trailing 12 Months (TTM) ending March 31, 2025, a -41.29% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.
  • NovoCure Limited Free Cash Flow Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -1.13, a 2,483.29% change year over year.
  • NovoCure Limited Free Cash Flow Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -0.04, a -112.55% change year over year.
  • NovoCure Limited Free Cash Flow Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 0.35, a -64.20% change year over year.
  • NovoCure Limited Free Cash Flow Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 0.98, a 344.33% change year over year.
Key Data
Date Free Cash Flow Per Share Dividend Per Share Debt to Equity Ratio Quick Ratio